Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …

Atherosclerosis, chronic non-communicable diseases, and metabolic syndrome are highly
interconnected and collectively contribute to global health concerns that reduce life …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
represents the hepatic expression of several metabolic abnormalities of high epidemiologic …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, placing an increasing burden on human health. NAFLD is a complex …

Non‐Alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and is
characterized by fat accumulation in the liver. Hypercaloric diets generally increase hepatic …

Non-alcoholic fatty liver disease (NAFLD) is frequently associated with metabolic disorders,
being highly prevalent in obese and diabetic patients. Many concomitant factors that …

Metabolic inflammation (metaflammation) is characteristic of obesity-related metabolic
disorders, associated with increased risk of development of type 2 diabetes, nonalcoholic …

Background: Fructose providing excess calories in the form of sugar sweetened beverages
(SSBs) increases markers of non-alcoholic fatty liver disease (NAFLD). Whether this effect …

Национальный мультидисциплинарный Консенсус подготовлен при участии
Национальной медицинской Ассоциации по изучению сочетанных заболеваний …

Background and aims Excess energy intake can lead to metabolic dysfunction-associated
steatotic liver disease (MASLD), but the relationship between dietary carbohydrate intake …